search
Back to results

The Effect of Physiotherapy on Post POEM Reflux

Primary Purpose

Reflux, Gastroesophageal, Achalasia, Esophagitis

Status
Recruiting
Phase
Not Applicable
Locations
Czechia
Study Type
Interventional
Intervention
Physiotherapy
Control group
Sponsored by
Institute for Clinical and Experimental Medicine
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Reflux, Gastroesophageal focused on measuring Per-oral endoscopic myotomy, Reflux, Physiotherapy, Proton pump inhibitors, Diapraghm, Achalasia, Lower esophageal sphincter

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. esophageal achalasia (or other primary motility disease) treated by per oral endoscopic myotomy (POEM)
  2. symptomatic post-POEM reflux and/or esophagitis LA A/B/C (grade by The Los Angeles Classification) present 3 months after POEM surgery
  3. positive finding on esophageal 24hours pH Test 3 months after POEM surgery
  4. signed informed consent

Exclusion Criteria:

  1. reflux symptoms previously to the POEM surgery (except regurgitation)
  2. repeated POEM surgery
  3. Esophagitis of LA grade D
  4. asymptomatic pathologic reflux without signs of esophagitis 3 months post POEM surgery (patient is not indicated to use proton pump inhibitor "PPI" drugs)
  5. previous gastric surgery
  6. patients undergoing cancer treatment
  7. pregnancy
  8. known allergy or intolerance of proton pump inhibitor drugs
  9. other circumstances preventing participation in the study
  10. Inability to obtain informed consent

Sites / Locations

  • Institute for Clinical and Experimental MedicineRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Physiotherapy

Control group

Arm Description

Patients will undergo physiotherapy and will be regularly examined by an assigned physician. Initial physiotherapy will last 60minutes, other therapies will last 30minutes. Physiotherapy will aim on diaphragmatic breathing and dynamic neuromuscular stabilization exercises. In the 1st month, the patient attends physiotherapy once a week In the 2nd, 3rd and 4th month, the patient attends physiotherapy once every 14 days. Symptomatic patients will take PPIs based on the recommendation of the treating physician who will recommend a dose of PPIs. Used PPIs will be Emanera 1x40mg (standard dose), 2x40mg (higher dose) or 1x40mg on demand. During the follow-up period, patients may, in agreement with the attending physician, reduce the dose of PPIs (from twice a day to once a day, from once a day to an "on-demand" regime or discontinue them altogether). The use of PPIs will be accurately documented.

Control group will undergo standard treatment of reflux with PPIs and will be regularly examined by an assigned physician. Symptomatic patients will take PPIs based on the recommendation of the treating physician who will recommend a dose of PPIs. Used PPIs will be Emanera 1x40mg (standard dose), 2x40mg (higher dose) or 1x40mg on demand. All patients with esophagitis LA A/B/C will be treated with IPP-Emanera 1x40mg for at least 6 weeks at the start of the study. During the follow-up period, patients may, in agreement with the attending physician, reduce the dose of PPIs (from twice a day to once a day, from once a day to an "on-demand" regime or discontinue them altogether). The use of PPIs will be accurately documented.

Outcomes

Primary Outcome Measures

Comparison of proton pump inhibitor drugs usage in experimental and control group
Rate of use of IPP and only Emanera 2x40mg (higher dose), 1X40mg (standard dose), or 1x40 mg in case of problems or completely discontinue IPP

Secondary Outcome Measures

Comparison of diagnostic examinations
The secondary outputs will be the results of high resolution manometry examinations, where we monitor changes in pressure in the lower esophageal sphincter area and esophageal motility. The positivity and reflux rate will be demonstrated by 24hours pH testing and evaluated according to the De Meester score. Gastroscopy to evaluate the absence or presence of esophagitis.
Comparison of questionnaires
Evaluation of the Quality of life questionnaire of patients after POEM. Evaluation of the validated questionnaire for gastroesophageal reflux disease.

Full Information

First Posted
March 15, 2022
Last Updated
April 8, 2022
Sponsor
Institute for Clinical and Experimental Medicine
search

1. Study Identification

Unique Protocol Identification Number
NCT05326113
Brief Title
The Effect of Physiotherapy on Post POEM Reflux
Official Title
Effect of Physiotherapy on the Usage of Proton Pump Inhibitors and Changes in the Pressure of the Lower Esophageal Sphincter in Patients With Achalasia After Per Oral Endoscopic Myotomy
Study Type
Interventional

2. Study Status

Record Verification Date
April 2022
Overall Recruitment Status
Recruiting
Study Start Date
October 31, 2021 (Actual)
Primary Completion Date
October 18, 2023 (Anticipated)
Study Completion Date
January 18, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Institute for Clinical and Experimental Medicine

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Per-oral endoscopic myotomy has been used as a treatment method of esophageal achalasia. Patients who undergo POEM as a treatment of achalasia are often presented with development of reflux as a side effect of the surgery. Patients are then in need to use proton pump inhibitor drugs as a long term treatment of the reflux symptoms. Physiotherapy aimed on the strengthening of diaphragm and lower esophageal region is effective in gastroesophageal reflux disease. Therefore we are expecting positive effect of physiotherapy in post POEM patients with reflux symptoms and the possible reduction of PPI drug usage need. The aim of the study is to objectify the effect of physiotherapy, to describe in detail the used physiotherapeutic techniques and to develop practical guidelines for the treatment of patients after POEM with GERD.
Detailed Description
The goal per-oral endoscopic myotomy (POEM) is to release a non-relaxing, often spastic lower esophageal sphincter (LES). During POEM an incision of the esophageal muscle layer (m.propria) is performed using the submucosal tunnel technique. A complication of POEM is the development of reflux, which occurs in up to 50% of patients (within 12 months), with the occurrence of severe esophagitis being rare. However, patients are treated with proton pump inhibitors (PPIs) after POEM, either daily or on-demand. As a result, patients after POEM are regularly monitored for the possible development of symptomatic or asymptomatic reflux, which (if left untreated) can lead to the development of complications, including Barrett's esophagus, a known precancerous lesion. The main reason for reflux in patients after POEM is an insufficient function of the LES, which is formed not only by the smooth muscle of the esophagus, but also by the skeletal muscle- diaphragm, which remains intact during the POEM itself. Together, these two structures form a major component of antireflux barriers. Since the crural part of the diaphragm is a skeletal striated muscle, it is a trainable muscle. The study will involve 30 patients after POEM with diagnosed reflux. Three months after POEM patients undergo follow-up examinations using high resolution manometry, 24hours pH test for reflux and gastroscopy. Based on the results of the examination in the 3rd month after the POEM, those who meet the inclusion criteria, will be offered to participate in this study. Patients will be asked to fill in the quality of life questionnaire of patients after POEM and the validated questionnaire for patients with reflux disease. Patients will be randomized in 2 groups (15 in both arms, ratio 1:1), one group will undergo 4 months of physiotherapy treatment using PPI on demand, second group will be a control group undergoing standard treatment of reflux symptoms with PPI on demand. This study will evaluate the effect of standard treatment of post-POEM esophageal reflux compared to the effect of physiotherapy using dynamic neuromuscular stabilization in post-POEM patients with esophageal reflux. There is currently no study looking at the effect of physiotherapy in post-POEM patients, we believe this could be a beneficial study. If this study demonstrates that physiotherapy alleviates the symptoms of post-POEM reflux, it could be one of the official methods of treatment for this group of patients and thus significantly increase their quality of life.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Reflux, Gastroesophageal, Achalasia, Esophagitis
Keywords
Per-oral endoscopic myotomy, Reflux, Physiotherapy, Proton pump inhibitors, Diapraghm, Achalasia, Lower esophageal sphincter

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
30 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Physiotherapy
Arm Type
Experimental
Arm Description
Patients will undergo physiotherapy and will be regularly examined by an assigned physician. Initial physiotherapy will last 60minutes, other therapies will last 30minutes. Physiotherapy will aim on diaphragmatic breathing and dynamic neuromuscular stabilization exercises. In the 1st month, the patient attends physiotherapy once a week In the 2nd, 3rd and 4th month, the patient attends physiotherapy once every 14 days. Symptomatic patients will take PPIs based on the recommendation of the treating physician who will recommend a dose of PPIs. Used PPIs will be Emanera 1x40mg (standard dose), 2x40mg (higher dose) or 1x40mg on demand. During the follow-up period, patients may, in agreement with the attending physician, reduce the dose of PPIs (from twice a day to once a day, from once a day to an "on-demand" regime or discontinue them altogether). The use of PPIs will be accurately documented.
Arm Title
Control group
Arm Type
Active Comparator
Arm Description
Control group will undergo standard treatment of reflux with PPIs and will be regularly examined by an assigned physician. Symptomatic patients will take PPIs based on the recommendation of the treating physician who will recommend a dose of PPIs. Used PPIs will be Emanera 1x40mg (standard dose), 2x40mg (higher dose) or 1x40mg on demand. All patients with esophagitis LA A/B/C will be treated with IPP-Emanera 1x40mg for at least 6 weeks at the start of the study. During the follow-up period, patients may, in agreement with the attending physician, reduce the dose of PPIs (from twice a day to once a day, from once a day to an "on-demand" regime or discontinue them altogether). The use of PPIs will be accurately documented.
Intervention Type
Other
Intervention Name(s)
Physiotherapy
Intervention Description
After POEM, patient underwent physiotherapy consisting of diaphragmatic breathing and dynamic stabilization exercises and PPIs
Intervention Type
Drug
Intervention Name(s)
Control group
Intervention Description
All patients will be treated with standard course of PPIs after POEM without physiotherapy.
Primary Outcome Measure Information:
Title
Comparison of proton pump inhibitor drugs usage in experimental and control group
Description
Rate of use of IPP and only Emanera 2x40mg (higher dose), 1X40mg (standard dose), or 1x40 mg in case of problems or completely discontinue IPP
Time Frame
9-10 months
Secondary Outcome Measure Information:
Title
Comparison of diagnostic examinations
Description
The secondary outputs will be the results of high resolution manometry examinations, where we monitor changes in pressure in the lower esophageal sphincter area and esophageal motility. The positivity and reflux rate will be demonstrated by 24hours pH testing and evaluated according to the De Meester score. Gastroscopy to evaluate the absence or presence of esophagitis.
Time Frame
9-10 month
Title
Comparison of questionnaires
Description
Evaluation of the Quality of life questionnaire of patients after POEM. Evaluation of the validated questionnaire for gastroesophageal reflux disease.
Time Frame
9-10 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: esophageal achalasia (or other primary motility disease) treated by per oral endoscopic myotomy (POEM) symptomatic post-POEM reflux and/or esophagitis LA A/B/C (grade by The Los Angeles Classification) present 3 months after POEM surgery positive finding on esophageal 24hours pH Test 3 months after POEM surgery signed informed consent Exclusion Criteria: reflux symptoms previously to the POEM surgery (except regurgitation) repeated POEM surgery Esophagitis of LA grade D asymptomatic pathologic reflux without signs of esophagitis 3 months post POEM surgery (patient is not indicated to use proton pump inhibitor "PPI" drugs) previous gastric surgery patients undergoing cancer treatment pregnancy known allergy or intolerance of proton pump inhibitor drugs other circumstances preventing participation in the study Inability to obtain informed consent
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Kateřina Mádle
Phone
00420606613462
Email
katerina.madle@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Jan Martínek
Phone
00420723708839
Email
jan.martinek@volny.cz
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kateřina Mádle
Organizational Affiliation
Charles University 2nd faculty of medicine, Prague, Czech Republic
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Jan Martínek
Organizational Affiliation
Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Zuzana Vacková
Organizational Affiliation
Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Milan Martínek
Organizational Affiliation
Charles University Faculty of Physical Education and Sport
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Lucie Zdrhová
Organizational Affiliation
Department of Internal Medicine, Pilsen, Czech Republic
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Alena Kobesová
Organizational Affiliation
Charles University 2nd faculty of medicine, Prague, Czech Republic
Official's Role
Principal Investigator
Facility Information:
Facility Name
Institute for Clinical and Experimental Medicine
City
Prague 4
State/Province
Prague
ZIP/Postal Code
14021
Country
Czechia
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jan Martínek, MD. PhD.
Phone
+420723708839
Email
jan.martinek@volny.cz

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

The Effect of Physiotherapy on Post POEM Reflux

We'll reach out to this number within 24 hrs